切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2019, Vol. 12 ›› Issue (01) : 107 -111. doi: 10.3877/cma.j.issn.1674-6902.2019.01.025

所属专题: 文献

综述

血小板指数在慢性阻塞性肺疾病并发肺动脉高压中的研究进展
孙兰1, 华毛2,(), 冯喜英2   
  1. 1. 810000 西宁,青海大学研究生院
    2. 810000 西宁,青海大学附属医院呼吸科
  • 收稿日期:2018-06-25 出版日期:2019-02-20
  • 通信作者: 华毛
  • 基金资助:
    青海省科技厅项目(2014-Z-744)

Research progress of platelet index in pulumonary hypertension complicated and chronic obstructive pulmonary disease

Lan Sun1, Mao Hua2(), Xiying Feng2   

  • Received:2018-06-25 Published:2019-02-20
  • Corresponding author: Mao Hua
引用本文:

孙兰, 华毛, 冯喜英. 血小板指数在慢性阻塞性肺疾病并发肺动脉高压中的研究进展[J]. 中华肺部疾病杂志(电子版), 2019, 12(01): 107-111.

Lan Sun, Mao Hua, Xiying Feng. Research progress of platelet index in pulumonary hypertension complicated and chronic obstructive pulmonary disease[J]. Chinese Journal of Lung Diseases(Electronic Edition), 2019, 12(01): 107-111.

1
任成山,钱桂生. 慢性阻塞性肺疾病发病机制研究现状与展望[J/CD]. 中华肺部疾病杂志(电子版), 2009, 2(2): 104-115.
2
Günay E,SarnÇ Ulasl S, et al. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study[J]. Inflammation, 2014, 37(2): 374-380.
3
Zhang R,Tan X,He Q, et al. Comparison of symptom and risk assessment methods among patients with chronic obstructive pulmonary disease[J]. Chin Med J (Engl), 2014, 127(14): 2594-2598.
4
Calverley PM,Anderson JA,Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease[J]. N Engl J Med, 2007, 356(8): 775-789.
5
陈章,白小红,王利,等. 慢性阻塞性肺疾病患者血液流变学指标及ET、SOD水平变化的临床观察[J]. 微循环学杂志,2011, 21(2): 30-31.
6
王辰,曹大德,吴小青,等. 慢性肺原性心脏病急性发作期肺细小动脉血栓形成的病理观察[J]. 中华医学杂志,1997, (2): 44-46+82.
7
Gasparyan AY,Ayvazyan L,Mikhailidis DP, et al. Mean platelet volume: a link between thrombosis and inflammation?[J]. Curr Pharm Des, 2011, 17(1): 47-58.
8
Fenyo IM,Gafencu AV. The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis[J]. Immunobiology, 2013, 218(11): 1376-1384.
9
陈实, 李承红. 中性粒细胞/淋巴细胞比值与血小板/淋巴细胞比值与慢性阻塞性肺疾病的相关性研究[J]. 检验医学与临床,2017, 14(15): 2239-2240, 2244.
10
Karateke A,Kurt RK,Baloğ lu A. Relation of platelet distribution width (PDW) and platelet crit (PCT) to preeclampsia[J]. Ginekol Pol, 2015, 86(5): 372-375.
11
Wang M,Zhang J,Ji Q, et al. Evaluation of platelet distribution width in chronic obstructive pulmonary disease patients with pulmonary embolism[J]. Biomark Med, 2016, 10(6): 587-596.
12
Fu H,Qin B,Hu Z, et al. Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis[J]. Clin Lab, 2015, 61(3-4): 269-273.
13
Akboga MK,Canpolat U,Yuksel M, et al. Platelet to lymphocyte ratio as a novel indicator of inflammation is correlated with the severity of metabolic syndrome: A single center large-scale study[J]. Platelets, 2016, 27(2): 178-183.
14
Soriano JB,Visick GT,Muellerova H, et al. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care[J]. Chest, 2005, 128(4): 2099-2107.
15
王江莎, 肖建军. 老年COPD急性加重期患者血小板平均体积与CAPS评分及住院死亡的关系[J]. 浙江中西医结合杂志,2016, 26(2): 108-112.
16
Park Y,Schoene N,Harris W. Mean platelet volume as an indicator of platelet activation: methodological issues[J]. Platelets, 2002, 13(5-6): 301-306.
17
Davì G,Patrono C. Platelet activation and atherothrombosis[J]. N Engl J Med, 2007, 357(24): 2482-2494.
18
Kaya MG,Elcik D,Akpek M, et al. Mean platelet volume levels predict pulmonary artery hypertension in patients with atrial septal defect[J]. Acta Cardiol, 2014, 69(2): 161-166.
19
王政权,李刚,杨绍波,等. 血小板分布宽度和血小板平均体积在慢性阻塞性肺疾病合并肺动脉高压患者中的临床意义[J]. 昆明医科大学学报,2016, 37(3): 100-103.
20
Kodiatte TA,Manikyam UK,Rao SB, et al. Mean platelet volume in Type 2 diabetes mellitus[J]. J Lab Physicians, 2012, 4(1): 5-9.
21
Zheng YG,Yang T,Xiong CM, et al. Platelet distribution width and mean platelet volume in idiopathic pulmonary arterial hypertension[J]. Heart Lung Circ, 2015, 24(6): 566-572.
22
Bialas AJ,Pedone C,Piotrowski WJ, et al. Platelet distribution width as a prognostic factor in patients with COPD - pilot study[J]. Int J Chron Obstruct Pulmon Dis, 2017, 12: 2261-2267.
23
Bae MH,Lee JH,Yang DH, et al. White blood cell, hemoglobin and platelet distribution width as short-term prognostic markers in patients with acute myocardial infarction[J]. J Korean Med Sci, 2014, 29(4): 519-526.
24
Malerba M,Olivini A,Radaeli A, et al. Platelet activation and cardiovascular comorbidities in patients with chronic obstructive pulmonary disease[J]. Curr Med Res Opin, 2016, 32(5): 885-891.
25
Zhang M,Li Y,Zhang J, et al. Mean platelet volume is elevated in exacerbated and convalescent COPD patients[J]. Clin Chim Acta, 2015, 451(Pt B): 227-231.
26
Steiropoulos P,Papanas N,Nena E, et al. Mean platelet volume and platelet distribution width in patients with chronic obstructive pulmonary disease: the role of comorbidities[J]. Angiology, 2013, 64(7): 535-539.
27
白莉敏,袁开芬,赵国厚. 慢性阻塞性肺疾病血栓前状态研究进展[J]. 中国老年保健医学,2014, (6): 92-94.
28
Butkiewicz AM,Kemona-Chetnik I,Dymicka-Piekarska V, et al. Does smoking affect thrombocytopoiesis and platelet activation in women and men?[J]. Adv Med Sci, 2006, 51: 123-126.
29
徐君美. 不同程度慢性阻塞性肺病患者血栓前状态临床分析[J]. 中外医疗,2017, 36(19): 28-30.
30
陈豫钦, 王健. 慢性阻塞性肺疾病相关的肺动脉高压病理生理学研究进展[J]. 老年医学与保健,2018, 24(3): 229-232.
31
曾建明, 曾春芳. 痰热清注射液对慢性阻塞性肺疾病患者血清微量元素、血小板参数及活化功能的影响[J]. 海南医学院学报,2014, 20(3): 344-346, 349.
32
Humbert M,Morrell NW,Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension[J]. J Am Coll Cardiol, 20042017, 43(12 Suppl S): 13S-24S.
33
Can MM,Tanboğ a IH,Demircan HC, et al. Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study[J]. Thromb Res, 2010, 126(4): 280-282.
34
Varol E,Uysal BA,Ozaydin M. Platelet indices in patients with pulmonary arterial hypertension[J]. Clin Appl Thromb Hemost, 2011, 17(6): E171-E174.
35
Soon E,Holmes AM,Treacy CM, et al. Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension[J]. Circulation, 2010, 122(9): 920-927.
36
吴挺实,梁勇,陈钰. 慢性阻塞性肺疾病急性加重期患者的血小板活化及氧化应激变化研究[J]. 检验医学与临床,2016, 13(16): 2384-2386.
37
Sreeramkumar V,Adrover JM,Ballesteros I, et al. Neutrophils scan for activated platelets to initiate inflammation[J]. Science, 2014, 346(6214): 1234-1238.
38
郭璐,杨阳,蒋红丽,等. 血小板增多与慢性阻塞性肺疾病伴低危肺栓塞患者住院全因死亡的相关性分析[J]. 中国呼吸与危重监护杂志,2018, (01): 20-26.
39
陈珵, 徐侃. 血小板在炎症反应中作用的研究进展[J]. 海南医学,2017, 28(4): 623-626.
40
Vogelmeier CF,Criner GJ,Martínez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary[J]. Arch Bronconeumol, 2017, 53(3): 128-149.
41
Karadeniz G,Aktoğ u S,Erer OF, et al. Predictive value of platelet-to-lymphocyte ratio in exacerbation of chronic obstructive pulmonary disease[J]. Biomark Med, 2016, 10(7): 701-710.
42
孙旺远,高蔚,翁婷,等. 慢性阻塞性肺疾病患者血小板与淋巴细胞比值的变化及其临床意义[J]. 中国校医,2017, 31(11): 846-848, 850.
43
Kumar P,Law S,Sriram KB. Evaluation of platelet lymphocyte ratio and 90-day mortality in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. J Thorac Dis, 2017, 9(6): 1509-1516.
44
Duman D,Aksoy E,Agca MC, et al. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia[J]. Int J Chron Obstruct Pulmon Dis, 2015, 10: 2469-2478.
45
Yüksel O,Helvaci K,Basar O, et al. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume[J]. Platelets, 2009, 20(4): 277-281.
46
Kim DA,Kim TY. Controversies over the interpretation of changes of mean platelet volume in rheumatoid arthritis[J]. Platelets, 2011, 22(1): 79-80.
47
Kisacik B,Tufan A,Kalyoncu U, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis[J]. Joint Bone Spine, 2008, 75(3): 291-294.
48
Kim DS,Lee J,Kim SH, et al. Mean platelet volume is elevated in patients with psoriasis vulgaris[J]. Yonsei Med J, 2015, 56(3): 712-718.
49
Agapakis DI,Massa EV,Hantzis I, et al. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation[J]. Respir Care, 2016, 61(1): 44-49.
50
Wang RT,Li JY,Cao ZG, et al. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease[J]. Respirology, 2013, 18(8): 1244-1248.
51
Wood LG,Shivappa N,Berthon BS, et al. Dietary inflammatory index is related to asthma risk, lung function and systemic inflammation in asthma[J]. Clin Exp Allergy, 2015, 45(1): 177-183.
52
曹亮,赵建清,钱海红,等. 静脉血平均血小板体积对慢性阻塞性肺疾病急性加重恢复期患者的诊断价值[J]. 山东医药,2018, 58(17): 72-74.
53
金兵. 血小板平均体积在慢性阻塞性肺疾病急性加重期的变化[J]. 中国老年学杂志,2015, (24): 7103-7105.
54
王红阳,付爱双,王袁. 慢性阻塞性肺疾病急性加重期患者血清中CRP、TNF-α、IL-6、IL-8的检测及临床意义[J]. 中国现代医学杂志,2014, 24(26): 109-112.
55
李兰,张健,唐凤鸣. 抗血小板治疗在慢性阻塞性肺疾病急性加重期中的临床效果观察[J]. 广西医学,2017, 39(1): 107-109.
[1] 马锦芳, 何正光, 郑劲平. 盐酸氨溴索雾化吸入治疗慢性阻塞性肺疾病黏痰症患者的疗效和安全性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 568-574.
[2] 程炜炜, 张青, 张诚实, 冯契靓, 陈荣荣, 赵云峰. 全身免疫炎症指数与慢性阻塞性肺疾病急性加重期病情严重程度相关性分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 580-584.
[3] 罗霞, 王宝梅, 李淑景, 杨英. 特发性肺动脉高压血清PCSK9表达及预后意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 585-589.
[4] 杨万荣, 任治坤, 时新颍. 沙丁胺醇雾化吸入脾多肽治疗AECOPD的疗效分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 609-612.
[5] 赖乾德, 吕相琴, 蔺洋, 刘媛梅, 赵春艳, 李琦. 肝素结合蛋白对慢性阻塞性肺疾病预后预测分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 613-616.
[6] 王微, 丁霖, 陈茜, 呼延欣, 闫蓓. 综合治疗对慢性阻塞性肺疾病的疗效及转归影响分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 621-624.
[7] 方晓玉, 王婷, 赵珊, 陈锋. HALP指数对AECOPD并发呼吸衰竭患者ICU结局的预测意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 639-641.
[8] 郭少琳, 郭建英, 左秀萍, 高苗. 慢性阻塞性肺疾病康复训练依从性影响因素分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 652-654.
[9] 白若靖, 郭军. 维生素D对肺部疾病临床意义的研究进展[J]. 中华肺部疾病杂志(电子版), 2024, 17(04): 659-662.
[10] 朱佑君, 付万垒, 毛杨, 李德峰. 细胞外基质相关标志物与成纤维细胞在肺动脉高压发展中的意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 356-362.
[11] 孔令梅, 徐晓媛, 马丽颖. 慢性阻塞性肺疾病认知衰弱危险因素及预后分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 407-410.
[12] 徐艳, 江秀娟, 王超, 江圆满. 股直肌剪切波弹性成像对COPD并发肌少症的诊断意义[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 454-457.
[13] 黄映兰, 骆丽萍, 郭慧玲, 袁麟标. 慢性阻塞性肺疾病糖皮质激素治疗反应性的影响因素分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 469-471.
[14] 杨坤, 赵景成, 吴永强. 无创呼吸机在慢性阻塞性肺疾病并发呼吸衰竭救治的临床分析[J]. 中华肺部疾病杂志(电子版), 2024, 17(03): 481-483.
[15] 吴欣, 袁晓晨, 沈慧, 秦建华. 三尖瓣反流速度评估肺动脉高压患者心脏结构改变的研究[J]. 中华临床医师杂志(电子版), 2024, 18(03): 259-267.
阅读次数
全文


摘要